Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects
Status:
Terminated
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of topiramate (96 mg or 192
mg daily) as compared to placebo in maintaining weight loss in obese subjects who
participated in an eight week intensive non-pharmacologic weight loss program.
The primary efficacy endpoint will be the percent change in body weight from enrollment visit
to week 60.